Psychobiotics put the gut-brain axis on vets’ radar

The latest dvm360 coverage puts a spotlight on psychobiotics, a still-emerging category of probiotics aimed at supporting mental health through the gut-brain axis. In an April 29, 2026, interview from Fetch Charlotte, Callie Harris, DVM, said microbiota-driven signaling between the gut and brain may influence stress responses and mood in pets, with probiotic research pointing to lower cortisol and higher serotonin in some settings. The broader literature supports the biologic plausibility of that connection, but it also shows the field is early, strain-specific, and much stronger in concept and small studies than in large, practice-changing clinical trials. (dvm360.com)

Why it matters: For veterinary professionals, the takeaway isn't that probiotics are ready to replace behavior medicine. It's that nutrition and the microbiome are becoming more relevant in behavioral case work, especially for dogs with anxiety, chronic stress, or concurrent GI signs. Purina Institute materials cite a blinded crossover study in anxious dogs supplemented with Bifidobacterium longum reporting lower salivary cortisol and heart rate in many dogs, while reviews from the veterinary literature caution that evidence remains limited and product effects can't be generalized across strains or brands. That makes case selection, expectation setting with pet parents, and multimodal treatment planning especially important. (purinainstitute.com)

What to watch: Expect more discussion of psychobiotics in continuing education and industry nutrition channels, but the key next step for clinicians is whether larger, independent trials can show consistent behavioral benefits beyond selected products and controlled settings. (dvm360.com)